Introduction: Primary hyperparathyroidism (pHPT) in pregnancy is reported to be associated with significant maternal and foetal complications and a 3-fold miscarriage risk. The prevalence of pHPT in women between 20-40 years is now known to be 1 in 2000 but the incidence of pHPT in pregnancy, complete and miscarried, is unknown and just 11 of 1200 parathyroidectomies performed over a 10-year period were on pregnant women in our department. Until now there was no published data on the prevalence of pHPT in the recurrent miscarriage (RM) population, defined by the WHO as ≥3 consecutive miscarriages and affecting 1% of couples trying to conceive. This is the first prospective study on pHPT in RM and aimed to assess its clinical significance.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to European Journal of Surgical Oncology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
© 2017 Published by Elsevier Inc.